MULTIPLE SCLEROSIS TRIALS COLLABORATION (MSTC)
To provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials. Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise & administer research-led clinical trials thereby providing greater access to potential treatments to more MS patients.
Financial health, per its FY2025 accounts
The accounts state that the charity held total unrestricted funds of £335,694 at the year end, which is in line with its policy to hold reserves sufficient to cover three months of operational expenditure. The trustees confirmed that the budgeted income and expenditure are sufficient for the charity to continue as a going concern for at least 12 months from the authorization of the statements.
What the accounts disclose
“Its current policy is to hold unrestricted, undesignated reserves sufficient to cover three months operational expenditure.” — page 4
Trustees
- Dr OMAR MALIK
- Dr RICHARD ST JOHN NICHOLAS
- JEREMY CHATAWAY
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £51k | £4k |
| 31/03/2024 | £51k | £16k |
| 31/03/2023 | £103k | £51k |
| 31/03/2022 | £58k | £26k |
| 31/03/2021 | £3k | £41k |
Common questions
Is MULTIPLE SCLEROSIS TRIALS COLLABORATION (MSTC) financially healthy?
Per its FY2025 accounts: The accounts state that the charity held total unrestricted funds of £335,694 at the year end, which is in line with its policy to hold reserves sufficient to cover three months of operational expenditure. The trustees confirmed that the budgeted income and expenditure are sufficient for the charity to continue as a going concern for at least 12 months from the authorization of the statements. Its FY2025 accounts were independently examined.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 15/05/2020 | £29k | Supporting vulnerable families through Covid-19 |